Structure-Activity Relationship Studies of 4-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-6-imino-N-(naphthalen-2-yl)-1,3,5-triazin-2-amine (FPMINT) Analogues as Inhibitors of Human Equilibrative Nucleoside Transporters.

Saved in:
Bibliographic Details
Title: Structure-Activity Relationship Studies of 4-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-6-imino-N-(naphthalen-2-yl)-1,3,5-triazin-2-amine (FPMINT) Analogues as Inhibitors of Human Equilibrative Nucleoside Transporters.
Authors: Li R; Department of Pharmacology and Pharmacy, University of Hong Kong, Pokfulam, Hong Kong SAR, China., Mak WW; Department of Pharmacology and Pharmacy, University of Hong Kong, Pokfulam, Hong Kong SAR, China., Li J; Department of Pharmacology and Pharmacy, University of Hong Kong, Pokfulam, Hong Kong SAR, China., Zheng C; Department of Pharmacology and Pharmacy, University of Hong Kong, Pokfulam, Hong Kong SAR, China., Shiu PH; Department of Pharmacology and Pharmacy, University of Hong Kong, Pokfulam, Hong Kong SAR, China., Seto SW; Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Kowloon, Hong Kong SAR, China., Lee SM; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, China., Leung GP; Department of Pharmacology and Pharmacy, University of Hong Kong, Pokfulam, Hong Kong SAR, China.
Source: Frontiers in pharmacology [Front Pharmacol] 2022 Feb 21; Vol. 13, pp. 837555. Date of Electronic Publication: 2022 Feb 21 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35264969
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Structure-Activity Relationship Studies of 4-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-6-imino-N-(naphthalen-2-yl)-1,3,5-triazin-2-amine (FPMINT) Analogues as Inhibitors of Human Equilibrative Nucleoside Transporters.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Li+R%22">Li R</searchLink>; Department of Pharmacology and Pharmacy, University of Hong Kong, Pokfulam, Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Mak+WW%22">Mak WW</searchLink>; Department of Pharmacology and Pharmacy, University of Hong Kong, Pokfulam, Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Li+J%22">Li J</searchLink>; Department of Pharmacology and Pharmacy, University of Hong Kong, Pokfulam, Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Zheng+C%22">Zheng C</searchLink>; Department of Pharmacology and Pharmacy, University of Hong Kong, Pokfulam, Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Shiu+PH%22">Shiu PH</searchLink>; Department of Pharmacology and Pharmacy, University of Hong Kong, Pokfulam, Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Seto+SW%22">Seto SW</searchLink>; Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Kowloon, Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Lee+SM%22">Lee SM</searchLink>; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, China.<br /><searchLink fieldCode="AU" term="%22Leung+GP%22">Leung GP</searchLink>; Department of Pharmacology and Pharmacy, University of Hong Kong, Pokfulam, Hong Kong SAR, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2022 Feb 21; Vol. 13, pp. 837555. <i>Date of Electronic Publication: </i>2022 Feb 21 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35264969
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fphar.2022.837555
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 837555
    Titles:
      – TitleFull: Structure-Activity Relationship Studies of 4-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-6-imino-N-(naphthalen-2-yl)-1,3,5-triazin-2-amine (FPMINT) Analogues as Inhibitors of Human Equilibrative Nucleoside Transporters.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Li R
      – PersonEntity:
          Name:
            NameFull: Mak WW
      – PersonEntity:
          Name:
            NameFull: Li J
      – PersonEntity:
          Name:
            NameFull: Zheng C
      – PersonEntity:
          Name:
            NameFull: Shiu PH
      – PersonEntity:
          Name:
            NameFull: Seto SW
      – PersonEntity:
          Name:
            NameFull: Lee SM
      – PersonEntity:
          Name:
            NameFull: Leung GP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 21
              M: 02
              Text: 2022 Feb 21
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 1663-9812
          Numbering:
            – Type: volume
              Value: 13
          Titles:
            – TitleFull: Frontiers in pharmacology
              Type: main
ResultId 1